J Gerontol A Biol Sci Med Sci:IL-6水平升高可导致老人谵妄的发生?

2015-07-29 sunshine 译 MedSci原创

对术后患者的研究表明,炎症因子水平的升高与患者谵妄的发生相关。谵妄是一种严重的精神错乱,往往发生在老年人术后或者身患重大疾病的时候。目前,由贝斯以色列女执事医疗中心(BIDMC)所进行的一项新的研究证实,炎症(身体遭受有害刺激时机体的一种保护性免疫反应)在谵妄的发生中起重要作用,该研究成果发表于The Journals of Gerontology, Series A: Biological Sc


对术后患者的研究表明,炎症因子水平的升高与患者谵妄的发生相关。

谵妄是一种严重的精神错乱,往往发生在老年人术后或者身患重大疾病的时候。目前,由贝斯以色列女执事医疗中心(BIDMC)所进行的一项新的研究证实,炎症(身体遭受有害刺激时机体的一种保护性免疫反应)在谵妄的发生中起重要作用,该研究成果发表于The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences

该研究发现,患有谵妄的老年人其炎症标志物白细胞介素-6(IL-6)的水平在术后两天明显升高,且确定了神志昏迷的患者其白细胞介素-2的水平也明显升高。这些发现可帮助临床医生确定极易发生谵妄的患者并辅助治疗谵妄。高达64%的住院老人发生过谵妄,而且谵妄可增加两到三倍随后发生老年痴呆的风险。

“美国每年数以百计的谵妄患者停留在综合性医院,”共同资深作者Edward Marcantonio说道,“IL-6与谵妄密切相关,IL-2与谵妄有关,表明炎症的确是引起谵妄的一个基本的机制。”
任何引起组织损伤的东西,包括感染,疾病或外科手术,都可以激活各种免疫细胞,引发炎症反应。“谵妄可能是一种炎症反应消失的状态,”Marcantonio说道。

本研究中,研究的共同作者Sarinnapha M. Vasunilashorn分析了来自SAGES的数据。在过去的五年里,该研究随访了566名70岁以上的非心脏手术患者,目的是为了找到防止老人发生谵妄的新方法并探究其长期效果。“在检查SAGES患者(曾接受过重大择期性手术)的过程中,我们比较了术后发生及未发生谵妄的患者,”Vasunilashorn解释道。手术的类型包括骨科、血管和胃肠道手术。

校正一些可能增加阿尔茨海默症发病风险的因素(包括年龄、性别、手术类型、基线认知、合并血管疾病、基因突变),作者采用一种三阶段法来检测炎症因子与谵妄之间的关联。

研究纳入272名SAGES患者,匹配过程中确定了39对谵妄和非谵妄人员,称为发现队列。然后剩余的SAGES患者中匹配了36对病例与对照人员,称为复制队列。最后他们将这两个队列结合起来以创建汇集队列,总共包含75个配对。

“结果显示,术后两天发生谵妄的患者其IL-6的水平显著升高,”Vasunilashorn说道,“神志昏迷与神志正常的患者相比,IL-6的水平相差巨大,高于正常老人上限了10倍。”

中等证据报道IL-2:汇集队列中,神志不清的患者较神志正常的患者IL-2的水平在四个点上更高。“IL-2在谵妄中的作用是一个新的发现,而且有趣的是,动物模型中发现IL-2可导致血脑屏障功能障碍。”

“尽管我们发现IL-6水平的升高与患者术后两天发生谵妄显著相关,我们并没有发现术后一个月这种升高与谵妄之间的关联具有统计学意义,”共同作者 Ngo说道,“IL-6水平升高的持续时间与谵妄严重性或谵妄持续性是否相关?这个问题尚未解决。但是,通过确定强大的IL-6信号,我们就有很好的机会来研究IL-6与谵妄之间的因果关系。”

“谵妄是住院老人最常见的并发症,”Marcantonio说道,“曾经认为谵妄是个短期、短暂的状态,现在有证据表明,谵妄及其影响可在病人离院以后持续存在。我们希望我们的病人在离院以后情况可以好转而不是恶化。理解炎症在谵妄发生中的作用,可以帮助我们确定哪些患者发生谵妄的风险最高,并可采取措施,以减小其发病的风险。还可以帮助我们设计新的干预措施,以防止或治疗谵妄。”

原始出处:

Research provides strong link between delirium and inflammation in older patients.MNT.July 28,2015

Vasunilashorn SM, Ngo L, Inouye SK, Libermann TA, Jones RN, Alsop DC, Guess J, Jastrzebski S, McElhaney JE, Kuchel GA, Marcantonio ER.Cytokines and Postoperative Delirium in Older Patients Undergoing Major Elective Surgery.J Gerontol A Biol Sci Med Sci. 2015 Jul 27.


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=368794, encodeId=1a66368e9428, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=526e2567988, createdName=小微940490, createdTime=Mon Jul 01 22:23:31 CST 2019, time=2019-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766957, encodeId=89af1e66957b6, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Tue Jan 19 19:42:00 CST 2016, time=2016-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021499, encodeId=4dee2021499a8, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Thu Feb 04 07:42:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917179, encodeId=16bb191e17953, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Thu Jun 30 04:42:00 CST 2016, time=2016-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273748, encodeId=702312e3748c7, content=<a href='/topic/show?id=fae896e7ea' target=_blank style='color:#2F92EE;'>#IL-6#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9677, encryptionId=fae896e7ea, topicName=IL-6)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Fri Jul 31 13:42:00 CST 2015, time=2015-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606560, encodeId=87281606560fc, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jul 31 13:42:00 CST 2015, time=2015-07-31, status=1, ipAttribution=)]
    2019-07-01 小微940490

    不错

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=368794, encodeId=1a66368e9428, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=526e2567988, createdName=小微940490, createdTime=Mon Jul 01 22:23:31 CST 2019, time=2019-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766957, encodeId=89af1e66957b6, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Tue Jan 19 19:42:00 CST 2016, time=2016-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021499, encodeId=4dee2021499a8, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Thu Feb 04 07:42:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917179, encodeId=16bb191e17953, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Thu Jun 30 04:42:00 CST 2016, time=2016-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273748, encodeId=702312e3748c7, content=<a href='/topic/show?id=fae896e7ea' target=_blank style='color:#2F92EE;'>#IL-6#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9677, encryptionId=fae896e7ea, topicName=IL-6)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Fri Jul 31 13:42:00 CST 2015, time=2015-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606560, encodeId=87281606560fc, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jul 31 13:42:00 CST 2015, time=2015-07-31, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=368794, encodeId=1a66368e9428, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=526e2567988, createdName=小微940490, createdTime=Mon Jul 01 22:23:31 CST 2019, time=2019-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766957, encodeId=89af1e66957b6, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Tue Jan 19 19:42:00 CST 2016, time=2016-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021499, encodeId=4dee2021499a8, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Thu Feb 04 07:42:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917179, encodeId=16bb191e17953, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Thu Jun 30 04:42:00 CST 2016, time=2016-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273748, encodeId=702312e3748c7, content=<a href='/topic/show?id=fae896e7ea' target=_blank style='color:#2F92EE;'>#IL-6#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9677, encryptionId=fae896e7ea, topicName=IL-6)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Fri Jul 31 13:42:00 CST 2015, time=2015-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606560, encodeId=87281606560fc, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jul 31 13:42:00 CST 2015, time=2015-07-31, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=368794, encodeId=1a66368e9428, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=526e2567988, createdName=小微940490, createdTime=Mon Jul 01 22:23:31 CST 2019, time=2019-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766957, encodeId=89af1e66957b6, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Tue Jan 19 19:42:00 CST 2016, time=2016-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021499, encodeId=4dee2021499a8, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Thu Feb 04 07:42:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917179, encodeId=16bb191e17953, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Thu Jun 30 04:42:00 CST 2016, time=2016-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273748, encodeId=702312e3748c7, content=<a href='/topic/show?id=fae896e7ea' target=_blank style='color:#2F92EE;'>#IL-6#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9677, encryptionId=fae896e7ea, topicName=IL-6)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Fri Jul 31 13:42:00 CST 2015, time=2015-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606560, encodeId=87281606560fc, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jul 31 13:42:00 CST 2015, time=2015-07-31, status=1, ipAttribution=)]
    2016-06-30 sunylz
  5. [GetPortalCommentsPageByObjectIdResponse(id=368794, encodeId=1a66368e9428, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=526e2567988, createdName=小微940490, createdTime=Mon Jul 01 22:23:31 CST 2019, time=2019-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766957, encodeId=89af1e66957b6, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Tue Jan 19 19:42:00 CST 2016, time=2016-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021499, encodeId=4dee2021499a8, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Thu Feb 04 07:42:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917179, encodeId=16bb191e17953, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Thu Jun 30 04:42:00 CST 2016, time=2016-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273748, encodeId=702312e3748c7, content=<a href='/topic/show?id=fae896e7ea' target=_blank style='color:#2F92EE;'>#IL-6#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9677, encryptionId=fae896e7ea, topicName=IL-6)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Fri Jul 31 13:42:00 CST 2015, time=2015-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606560, encodeId=87281606560fc, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jul 31 13:42:00 CST 2015, time=2015-07-31, status=1, ipAttribution=)]
    2015-07-31 kzlchina
  6. [GetPortalCommentsPageByObjectIdResponse(id=368794, encodeId=1a66368e9428, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=526e2567988, createdName=小微940490, createdTime=Mon Jul 01 22:23:31 CST 2019, time=2019-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766957, encodeId=89af1e66957b6, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Tue Jan 19 19:42:00 CST 2016, time=2016-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021499, encodeId=4dee2021499a8, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Thu Feb 04 07:42:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917179, encodeId=16bb191e17953, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Thu Jun 30 04:42:00 CST 2016, time=2016-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273748, encodeId=702312e3748c7, content=<a href='/topic/show?id=fae896e7ea' target=_blank style='color:#2F92EE;'>#IL-6#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9677, encryptionId=fae896e7ea, topicName=IL-6)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Fri Jul 31 13:42:00 CST 2015, time=2015-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606560, encodeId=87281606560fc, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jul 31 13:42:00 CST 2015, time=2015-07-31, status=1, ipAttribution=)]

相关资讯

J Periodontol:男性睾酮的水平与牙周炎的发生发展有关

J Periodontol:男性睾酮的水平与牙周炎的发生发展有关性激素与炎症以及骨代谢有关。本研究的目的是为了探讨男性性激素与牙周炎之间的关系。数据来源于第三次国民健康和营养调查(NHANES)。分析755名男性(年龄≥30岁)的血清睾酮,雌二醇,性激素结合球蛋白(SHBG)以及雄烯二醇葡萄糖苷酸(AAG)的水平。计算睾固酮以及雌二醇睾酮比值。使用最新牙周炎累及范围和严重程度分类来评估研究对象的牙

Nutrients:鸡蛋胆固醇不可怕,降低炎症也有它

糖尿病患者早餐吃一个鸡蛋和吃一碗燕麦粥是一样健康的?甚至鸡蛋更健康?College of Agriculture, Health, and Natural Resources的营养学教授Maria-Luz Fernandez的最新研究成果表示鸡蛋可能对糖尿病患者属于更健康的饮食。Fernandez教授和她的同事们得到的证据表明,一个鸡蛋可能不仅属于糖尿病患者饮食中可以接受的类别,它可能会被证明提供

Oncogene:癌细胞之无间道

肿大的淋巴结常常是癌症细胞转移扩散最早期的征象。最近,来自瑞典卡罗林斯卡研究所的癌症研究人员及免疫学家们发现了,癌症细胞是如何伪装成免疫细胞(白细胞),从而进入到淋巴系统中的。研究人员们希望这项发表于Oncogene杂志上的研究发现,可以为新药开发提供新的信息。人们死于癌症的主要原因是,癌症在一些重要器官,如肺脏及肝脏,扩散形成子肿瘤,或称为肿瘤转移。癌症细胞扩散的主要途径之一是利用淋巴系统。在进

Cell Metab:靶向作用炎症有效抵御肥胖疾病

肥胖是引发很多疾病的风险因子,比如糖尿病、肝硬化以及慢性肾脏疾病等,脂肪炎症似乎是肥胖相关疾病的共同特性;近日来自都柏林大学的研究人员通过研究发现,机体中的一种特殊分子或可通过减缓逆转脂肪炎症来保护机体抵御肥胖相关疾病的发生,相关研究刊登于国际杂志Cell Metabolism上,该研究或为后期开发治疗肥胖及其相关病症的疗法提供希望。 炎症是机体对损伤的一部分天然反应,而脂氧素是一种帮助机体清除

PNAS:炎症让生物钟暂停

刊登在国际杂志PNAS上的一篇研究论文中,来自宾夕法尼亚大学等处的研究人员通过研究揭开了机体生物钟和免疫细胞的关联,或为开发治疗机体炎症及感染性疾病的新型疗法提供一定的帮助。文章中,研究人员阐明了当白细胞暴露于细菌中时其内部的生物钟被阻断的分子机制,而更重要的是,阻断白细胞的生物钟可以促进细胞变得具有较高活性,而且易于引发炎性表现。而miR155就是参与上述复杂机制的一种因子,其可以破坏生物钟机制

Cell Res:中科院全新成果--高盐饮食的危害

钠是人体不可获取的一种营养成分,适量的钠对细胞的正常功能非常关键。机体需要用钠维持渗透压、体液分布、pH值和绝大多数代谢过程。而钠离子流入细胞膜是神经冲动和肌肉收缩的基础。如今我们的食物中含有大量的钠盐,高盐饮食已经成为了公共健康的一大威胁。众所周知,高盐饮食与许多疾病风险有关。然而人们对这其中的机制却知之甚少。中国科学院的研究人员日前在Cell Research杂志上发表文章指出,高水平的盐会使